BMJ Open Diabetes Research & Care is a high-quality source for basic and clinical research regarding type 1 and type 2 diabetes, and associated complications. A rapid review process — and continuous online updates — ensure the publication of timely research.
Published by BMJ in partnership with the American Diabetes Association.
Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome
Glucagon-like peptide-1 (GLP-1) receptor activation delays the progression of diabetic nephropathy (DN) in rodents. The NOD-like
receptor 3 (Nlrp3) inflammasome plays an important role in DN.
Read this free article chosen by the Editor >>
Receive the latest table of contents via email. Be the first to download breakthrough articles.
Register here >>
PubMed and Scopus Indexed
BMJ Open Diabetes Research & Care articles are now discoverable via PubMed and PubMed Central and in Scopus.
View the Archive >>
In the news
See where BMJ Open Diabetes Research & Care has been mentioned in the media and read stories that cite its published articles.
Click here >>
See what your colleagues are reading and stay informed on the latest advances in diabetes research and treatment.
Most read >>